Vimarsana
Biggest News Aggregation in the World

Page 10 - Mouse Model News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mouse Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mouse Model Today - Breaking & Trending Today

XPro1595 Improves Outcomes in a Mouse Model of TBI-induced Alzheimer's Disease Seite 1 - Vimarsana News

XPro1595 Improves Outcomes in a Mouse Model of TBI-induced Alzheimer's Disease Seite 1

19.04.2023 - TNF is involved in the development of Alzheimer’s Disease pathology following traumatic brain injury and is prevented by neutralization of soluble TNF by XPRO Boca Raton, Florida, April 19, 2023 (GLOBE NEWSWIRE) -  INmune Bio, Inc. (NASDAQ: INMB) ... Seite 1

Dr Fashemi on the Effect of Entinostat on Olaparib Responsiveness in Mouse HRP Ovarian Cancer Models - Vimarsana News

Dr Fashemi on the Effect of Entinostat on Olaparib Responsiveness in Mouse HRP Ovarian Cancer Models

Bisiayo Fashemi, PhD, discusses how the addition of entinostat to olaparib could help combat PARP inhibitor-resistance in homologous recombination proficient ovarian cancer, as well as the clinical significance of utilizing mouse organoid models to investigate such strategies.

Dr John on the Antitumor Effects of Sulindac in an Obesity-Driven Model of Endometrial Cancer - Vimarsana News

Dr John on the Antitumor Effects of Sulindac in an Obesity-Driven Model of Endometrial Cancer

Catherine John, MD, discusses the antitumor effects of sulindac on the prevention and treatment of obesity-driven models of endometrial cancer.

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Year-End 2022 Update on Operations - Vimarsana News

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Year-End 2022 Update on Operations

Initiated patient enrollment in a Phase II open-label clinical trial investigating the safety, tolerability, and efficacy of CardiolRx in patients with recurrent pericarditis - a debilitating heart disease

Cardiol Therapeutics Announces Year-End 2022 Update on Operations - Vimarsana News

Cardiol Therapeutics Announces Year-End 2022 Update on Operations

Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart... | March 29, 2023